Exchange-weighted xenon-129 nuclear magnetic resonance system and related method

• US 7,805,176 B2
• Filed: 03/09/2005
• Issued: 09/28/2010
• Est. Priority Date: 03/10/2004
• Status: Active Grant

• Current Assignee: University of Virginia Patent Foundation (University of Virginia)
• Original Assignee: University of Virginia Patent Foundation (University of Virginia)
• Inventors: Brookeman, James R., Mugler, John P. III, Ruppert, Kai
• Primary Examiner(s): Le; Long V
• Assistant Examiner(s): Brutus; Joel F
• Application Number:
  US10/592,200
• Publication Number:
  US 20070225592A1
• Time in Patent Office: 2,029 Days
• Field of Search: 600/420, 600/431, 424/9.3
• US Class Current: 600/407
• CPC Class Codes: A61B 5/0515 Magnetic particle imaging
• CPC Class Codes: A61B 5/055 involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
• CPC Class Codes: A61B 5/726 using Wavelet transforms

Abstract

Method and system that provides, among other things, the capability for using hyperpolarized xenon-129 as a probe to non-invasively and non-destructively characterize important properties of certain structures or materials into which hyperpolarized xenon-129 can be introduced and wherein the xenon exists in two or more chemically-shifted states that are in exchange High-resolution MR images can be generated in a fraction of a second wherein the associated signal intensities reflect material properties that characterize the gas exchange among the different states. For example, in the human or animal lung, the system and related method can exploit the differences in gas-exchange characteristics between healthy and diseased lung tissue to generate high-resolution, high signal-to-noise cross-sectional MR images that permit non-invasive regional detection of variations in lung tissue structure with a combination of spatial and temporal resolution that is unmatched by any current imaging modality.

Claims

1. A method of characterizing properties of a lung, the lung having at least one compartment therein, said at least one compartment defining at least one reference compartment and the lung having at least one other compartment therein, said at least one other compartment defining at least one target compartment, said method comprising:

a) introducing hyperpolarized xenon-129 gas in the lung and

placing the lung in a NMR or MRI system;

b) creating transverse magnetization from the hyperpolarized xenon-129 gas in at least one of the reference compartments that has a corresponding chemical shift;

c) leaving the NMR or MRI system unperturbed for an appropriately chosen delay time, wherein

said delay time is chosen such that a sufficiently large quantity of xenon-129 atoms enter the target compartments from the reference compartment, the xenon-129 transverse magnetization in the target compartments acquires a relatively large range of phase shifts with respect to the transverse magnetization in the reference compartment, and xenon-129 atoms in the target compartments diffuse back to the compartment boundary where they exchange with the reference compartment, thereby defining an exchange process, and

upon return to the reference compartment the transverse magnetization is dephased relative to that which remained in the reference compartment and this transverse magnetization from the target compartments thus makes a reduced contribution to the coherent gas-phase signal, which results in a reduced net signal from alveolar gas-phase transverse magnetization compared to the situation wherein there is relatively reduced or no xenon exchange between the reference and target compartments;

d) measuring said signal from hyperpolarized xenon-129 in the reference compartment; and

e) processing said signal from hyperpolarized xenon-129 in the reference compartment to determine a difference in at least one gas-exchange property of said lung among at least two spatial locations;

wherein the target compartment comprises at least a portion of a least one of lung parenchyma and lung alveolar capillary bed, and wherein the reference compartment comprises at least a portion of the lung.

2. The method of claim 1, wherein duration of said delay time is chosen based on at least one of:

external magnetic field strength, exchange rate between the reference compartment and target compartments, residence time of xenon-129 within the target compartment(s) and xenon-129 diffusion properties in the target compartment(s).

3. The method of claim 1, wherein said measured signal from the reference compartment reflects the degree of dephasing of the xenon-129 transverse magnetization inside the target compartments with respect to the reference compartment of step (c), and the time constants, partition coefficients and geometrical factors characterizing the xenon exchange between the reference and target compartments.

4. The method of claim 3, wherein information that the measured signal reflects depends on the difference in resonance frequency between the reference and the target compartments.

5. The method of claim 4, wherein said information comprises volume of material in which the xenon dissolves.

6. The method of claim 1, wherein said signal from hyperpolarized xenon-129 in the reference compartment at step (d) may also reflect other independent processes.

7. The method of claim 6, wherein said other independent processes comprise at least one of T1 and T2 relaxation and diffusion of xenon in the reference compartment.

8. The method of claim 7, further comprising selecting an appropriately designed pulse sequence.

9. The method of claim 8, wherein said selected pulse sequence and said chosen delay time ensures that contributions to said measured signal from said other independent processes are insignificant relative to that from said exchange process.

10. The method of claim 1, wherein the at least a portion of the lung is from an animal or human.

11. The method of claim 10, wherein the lung may be in vivo or excised.

12. The method of claim 1, wherein the characterizing properties provide means to nondestructively determine properties of certain materials.

13. The method of claim 1, wherein said measured signal reflects the signal from all Xe129 nuclei within the lung.

14. The method of claim 1, wherein said measured signal reflects the signal from Xe129 nuclei within one or more selected sub-volumes within the whole of the lung, wherein each said sub-volume may correspond to a planar slice of lung tissue, a column of lung tissue, or some arbitrarily-shaped volume of lung tissue.

15. The method of claim 1, wherein at least one magnetic field gradient pulse is applied for at least one of before and during the acquiring of said measured signal in any manner consistent with imaging pulse sequences known in the art to permit an exchange-weighted magnetic resonance image, resolved in one, two or three spatial dimensions, to be calculated.

16. The method of claim 15, wherein exchange-weighted magnetic resonance images are acquired corresponding to one or more spatial locations.

17. The method of claim 1, wherein in step (c) said transverse magnetization is manipulated by at least one of at least one suitably balanced magnetic field gradient and at least one refocusing RF pulse.

18. A system for characterizing properties of a lung, the lung having at least one compartment therein, said at least one compartment defining at least one reference compartment and the lung having at least one other compartment therein, said at least one other compartment defining at least one target compartment, said system comprising:

a) an NMR or MRI system adapted to allow;

introduction of hyperpolarized xenon-129 gas in the lung and

placement of the lung in an NMR or MRI system;

b) said NMR or MRI system adapted to allow;

creation of a transverse magnetization from the hyperpolarized xenon-129 gas in at least one of the reference compartments that has a corresponding chemical shift;

c) said NMR or MRI system adapted to allow;

leaving said NMR or MRI system substantially unperturbed for an appropriately chosen delay time, wherein

said delay time is chosen such that a sufficiently large quantity of xenon-129 atoms enter the target compartments from the reference compartment, the xenon-129 transverse magnetization in the target compartments acquires a relatively large range of phase shifts with respect to the transverse magnetization in the reference compartment, and xenon-129 atoms in the target compartments diffuse back to the compartment boundary where they exchange with the reference compartment, thereby defining an exchange process, and

upon return to the reference compartment the transverse magnetization is dephased relative to that which remained in the reference compartment and this transverse magnetization from the target compartments thus makes a reduced contribution to the coherent gas-phase signal, which results in a reduced net signal from alveolar gas-phase transverse magnetization compared to the situation wherein there is relatively reduced or no xenon exchange between the reference and target compartments;

d) said NMR or MRI system adapted to allow;

measurement of said signal from hyperpolarized xenon-129 in the reference compartment; and

e) said NMR or MRI system adapted to allow;

processing of said signal from hyperpolarized xenon-129 in the reference compartment to determine a difference in at least one gas-exchange property of lung among at least two spatial locations;

wherein the target compartment comprises at least a portion of a least one of lung parenchyma and lung alveolar capillary bed, and wherein the reference compartment comprises at least a portion of the lung.

19. The system of claim 18, wherein duration of said delay time is chosen based on at least one of:

external magnetic field strength, exchange rate between the reference compartment and target compartments, residence time of xenon-129 within the target compartment(s) and xenon-129 diffusion properties in the target compartment(s).

20. The system of claim 18, wherein said measured signal from the reference compartment reflects the degree of dephasing of the xenon-129 transverse magnetization inside the target compartments with respect to the reference compartment of element (c), and the time constants, partition coefficients and geometrical factors characterizing the xenon exchange between the reference and target compartments.

21. The system of claim 20, wherein information that the measured signal reflects depends on the difference in resonance frequency between the reference and the target compartments.

22. The system of claim 21, wherein said information comprises volume of material in which the xenon dissolves.

23. The system of claim 18, wherein said measurement of said signal from hyperpolarized xenon-129 in the reference compartment may also reflect other independent processes.

24. The system of claim 23, wherein said other independent processes comprise at least one of T1 and T2 relaxation and diffusion of xenon in the reference compartment.

25. The system of claim 24, wherein said NMR or MRI system is adapted to further comprise selecting an appropriately designed pulse sequence.

26. The system of claim 25, wherein said selected pulse sequence and said chosen delay time ensures that contributions to said measured signal from said other independent processes are insignificant relative to that from said exchange process.

27. The system of claim 18, wherein the at least a portion of the lung is from an animal or human.

28. The system of claim 27, wherein the lung may be in vivo or excised.

29. The system of claim 18, wherein the characterizing properties provide means to nondestructively determine properties of certain materials.

30. The system of claim 18, wherein said measured signal reflects the signal from all Xe129 nuclei within the lung.

31. The system of claim 18, wherein said measured signal reflects the signal from Xe129 nuclei within one or more selected sub-volumes within the whole of the lung, wherein each said sub-volume may correspond to a planar slice of lung tissue, a column of lung tissue, or some arbitrarily-shaped volume of lung tissue.

32. The system of claim 18, wherein at least one magnetic field gradient pulse is applied for at least one of before and during the acquisition of said measured signal in any manner consistent with imaging pulse sequences known in the art to permit an exchange-weighted magnetic resonance image, resolved in one, two or three spatial dimensions, to be calculated.

33. The system of claim 32, wherein exchange-weighted magnetic resonance images are acquired corresponding to one or more spatial locations.

34. The system of claim 18, wherein in step (c) said transverse magnetization is manipulated by at least one of at least one suitably balanced magnetic field gradient and at least one refocusing RF pulse.